Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers

doi:10.4239/wjd.v11.i7.309

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6483)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

318

WORD

149

HTML

3318

Figures (1-6)

301

Tables (1-3)

242

Sum=4328

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

849

Download

1306

Sum=2155

Jul 15, 2020 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Jul 15, 2020; 11(7): 309-321
Published online Jul 15, 2020. doi: 10.4239/wjd.v11.i7.309

Table 1 The median of the parameters and the correlation between neuropathy clinical scores and biochemical parameters, visfatin, and oxidative stress biomarkers

	SPNSQ score, 5.66 ± 3.64	MNSI q, 4.5 ± 2.28	MNSI exam, 2.42 ± 1.99
Glucose, mg/dL, 154.0 ± 57.5	P = 0.099, r = 0.084	P = 0.110, r = 0.081	P = 0.110, r = 0.081
HbA1c, 7.68 ± 1.52	P = 0.099, r = 0.084	P = 0.062, r = 0.094	^bP < 0.01, r = 0.170
Creatinine, mg/dL, 0.81 ± 0.13	P = 0.017, r = -0.121	P = 0.053, r = -0.098	P = 0.143, r = 0.074
ALT, U/L, 22.3 ± 12.8	P = 0.177, r = 0.000	P = 0.518, r = 0.033	P = 0.585, r = 0.028
AST, U/L, 18.6 ± 7.8	P = 0.587, r = 0.028	P = 0.676, r = 0.021	P = 0.810, r = -0.012
LDL cholesterol, mg/dL, 118.12 ± 28.00	P = 0.077, r = 0.090	P = 0.151, r = 0.073	P = 0.868, r = 0.008
Triglycerides, mg/dL, 160.3 ± 85.0	P =0.123, r = 0.078	P = 0.355, r = 0.047	P = 0.994, r = 0.000
Vitamin B12, pg/mL, 425.5 ± 32.0	^aP < 0.05, r = 0.132	P = 0.062, r = 0.095	P = 0.049, r = 0.100
Visfatin, pg/mL, 19.34 ± 8.07	P = 0.579, r = 0.028	P = 0.330, r = 0.049	^aP < 0.05, r = 0.122
TOS, μmol H₂O₂/L, 12.91 ± 1.92	P = 0.417, r = 0.041	P = 0.340, r = 0.048	^aP < 0.05, r = 0.155
TAS, mmol Trolox Eq./L, 0.87 ± 0.14	P = 0.385, r = 0.044	P = 0.160, r = -0.071	^aP < 0.05, r = -0.127
OSI (Arbitrary units), r = 0.20, 15.29 ± 4.12	P = 0.283, r = 0.054	P = 0.170, r = 0,069	^bP < 0.01, P = 0.000
Total thiol, mmol/L, 0.51 ± 0.05	P = 0.070, r = -0.092	P = 0.053, r = -0.098	P = 0.251, r = -0.05
Native thiol, mmol/L, 0.35 ± 0.05	P = 0.822, r = 0.011	P = 0.903, r = -0.006	P = 0.864, r = -0.009
Thiol-disulfide, mmol/L, 0.08 ± 0.03	P = 0.059, r = -0.096	P = 0.069, r = -0.092	P = 0.270, r = -0.056

^aP < 0.05,

^bP < 0.01. SPNSQ: Subjective Peripheral Neuropathy Screen Questionnaire; MNSI q: Michigan Neuropathy Screening Instrument questionnaire; MNSI exam: Michigan Neuropathy Screening Instrument examination; HbA1c: Glycosylated hemoglobin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TOS: Total oxidant status; TAS: Total antioxidant status; OSI: Oxidative stress index; LDL: Low density lipoprotein.

Table 2 The correlation between the Michigan Neuropathy Screening Instrument neuropathy scores and visfatin with oxidative stress biomarkers

	MNSI q < 7	MNSI q ≥ 7	P value	MNSI exam < 2.5	MNSI exam ≥ 2.5	P value
Visfatin	19.15 ± 7.93	20.08 ± 8.62	0.357	18.32 ± 6.97	20.64 ± 9.16	< 0.01
TOS	12.88 ± 1.90	13.04 ± 2.01	0.486	12.64 ± 1.63	13.26 ± 2.20	< 0.05
TAS	0.88 ± 0.14	0.85 ± 0.13	0.102	0.88 ± 0.12	0.85 ± 0.15	< 0.05
OSI	15.14 ± 4.09	15.84 ± 4.23	0.178	14.62 ± 3.45	16.64 ± 4.72	< 0.01
Total thiol	0.51 ± 0.00	0.51 ± 0.05	0.385	0.52 ± 0.05	0.51 ± 0.05	0.228
Native thiol	0.35 ± 0.05	0.34 ± 0.06	0.570	0.35 ± 0.05	0.35 ± 0.06	0.638
Thiol-disulfide	0.08 ± 0.03	0.08 ± 0.03	0.850	0.08 ± 0.03	0.08 ± 0.03	0.399

MNSI q: Michigan Neuropathy Screening Instrument questionnaire; MNSI exam: Michigan Neuropathy Screening Instrument examination; TOS: Total oxidant status; TAS: Total antioxidant status; OSI: Oxidative stress index.

Table 3 The median of the parameters and the correlation between glucose, serum oxidative stress biomarkers, and visfatin with thiol groups

	Visfatin, 19.34 ± 8.07	Total thiol, 0.51 ± 0.05	Native thiol, 0.35 ± 0.05	Thiol-disulfide, 0.08 ± 0.03
Glucose, 154.0 ± 57.5	P < 0.05, r = 0.537	P < 0.01, r = -0.204¹	P < 0.05¹, r = -0.452¹	P < 0.01, r = 0.206
HbA1c, 7.68 ± 1.52	P < 0.05, r = 0.753	P < 0.01, r = -0.351¹	P < 0.05¹, r = -0.597¹	P < 0.01, r = 0.194
TOS, 12.91 ± 1.92	P < 0.05, r = 0.407	P < 0.05, r = -0.236¹	P < 0.05¹, r = -0.352¹	P < 0.01, r = 0.094
TAS, 0.87 ± 0.14	P < 0.05, r = -0.499¹	P < 0.01, r = 0.243	P < 0.05, r = 0.408	P < 0.01, r = -0.134¹
OSI, 15.29 ± 4.12	P < 0.05, r = 0.587	P < 0.05, r = -0.322¹	P < 0.05¹, r = -0.485¹	P < 0.01, r = 0.132
Visfatin		P < 0.01, r = -0.338¹	P < 0.01¹, r = -0.448¹	P = 0.092

¹Correlations with negative directions are presented. HbA1c: Glycosylated hemoglobin; TOS: Total oxidant status; TAS: Total antioxidant status; OSI: Oxidative stress index.

Citation: Buyukaydin B, Guler EM, Karaaslan T, Olgac A, Zorlu M, Kiskac M, Kocyigit A. Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers. World J Diabetes 2020; 11(7): 309-321
URL: https://www.wjgnet.com/1948-9358/full/v11/i7/309.htm
DOI: https://dx.doi.org/10.4239/wjd.v11.i7.309